Published on FORBES.com | Democrats have been pulling levers for decades to exert greater and greater government control over our health sector. But the more government gets involved, the more dysfunctional the market becomes. The left now contends that the mess can only be solved with a complete government takeover. They believe their moment has come. Americans are … [Read more...] about The Left’s Utopian Health Care Promises
A Tale of Two Big (Medicare) Mistakes
So here is a glimpse into one small part of the vast U.S. health care industry that shows the incredible difficulty government agencies have in setting accurate and fair payment rates for medical services, even when specifically directed by Congress to do so. It offers a cautionary tale for those who would put the entire health care system under government control. The players in … [Read more...] about A Tale of Two Big (Medicare) Mistakes
Americans are in no mood for another health care upheaval
Published in The Los Angeles Times | PAEONIAN SPRINGS, Va. Conservatives and progressives agree that everyone should be able to get health insurance and have access to quality health care. But the divide over how to accomplish that goal is wide and deep. Progressives believe the government should make decisions about allocation of the resources in our health sector while conservatives … [Read more...] about Americans are in no mood for another health care upheaval
A Closer Look At The Drug Rebate Proposal
Last fall, I wrote in Forbes about U.S. based biotechnology manufacturer Amgen announcing it was slashing the list price of its breakthrough cholesterol-lowering drug Repatha by 60% in an effort to improve access and affordability for patients. Too many patients who had been prescribed the drug were walking away from the pharmacy empty handed because of sticker shock over … [Read more...] about A Closer Look At The Drug Rebate Proposal
Rebates And Drug Costs: What The New Proposal Would Mean
The Trump administration is trying in myriad ways to answer demands from consumers for lower prescription drug prices—a topic that got serious attention before the Senate Finance Committee on Tuesday where top executives of seven major drug companies testified. The president announced his “American Patients First” agenda in May, offering nearly 30 policy recommendations to … [Read more...] about Rebates And Drug Costs: What The New Proposal Would Mean
Do Democrats Want to Roll Back Consumer-Friendly Health Options?
If they said it once, they said it 200 at times. At a recent hearing before the House Energy and Commerce Health subcommittee (live-streamed here), the majority members repeatedly called the new Short Term Limited Duration plan option “Junk Plans.” In my testimony, I talked about the benefits these plans offer to people who are between jobs, young people in the gig economy, early … [Read more...] about Do Democrats Want to Roll Back Consumer-Friendly Health Options?
Preview Of The Coming Medicare For All Debate
The pre-existing condition scare tactics continue. I testified yesterday—as the sole witness called by the Republican minority—during a House Education and Labor Committee hearing on “Examining Threats to Workers with Preexisting Conditions.” It was the first hearing of the new Congress under the new Chairman Bobby Scott, D-VA, and virtually all members on both sides of the … [Read more...] about Preview Of The Coming Medicare For All Debate
Medicaid and Work: Crisis in Arkansas?
In a new piece for RealClearHealth, Doug Badger and I look at the data regarding work requirement for some Medicaid recipients in Arkansas and find the shrill criticism of the program is not supported by facts. Arkansas is one of seven states that have obtained permission from the Trump administration to establish work requirements in its Medicaid program, and the administration is … [Read more...] about Medicaid and Work: Crisis in Arkansas?